Creating Healthcare Unicorns: Ex-Novartis CFO Shares Secret Sauce
Executive Summary
Ex-Novartis executive and co-founder of investment bank MM Dillon & Co shares insights around where healthcare unicorns can be found and some core criteria to build such firms.
You may also be interested in...
J&J’s Gorsky Puts Spotlight On Big Picture Potential Of Asia, New Technologies
Keep your eyes on Asia, both for groundbreaking innovation and huge market opportunities, says Alex Gorsky, executive chairman of Johnson & Johnson. He also outlines exciting possibilities as biology and chemistry are being “fundamentally digitized.”
APAC Life Sciences Valuation Trends: Chinese Firms Eclipse Japan, India Peers
Chinese healthcare and life sciences firms now overshadow their peers in Japan and India in terms of key valuation metrics amid COVID-19 and China has also witnessed significant M&A activity at high revenue multiples.
Riding On Exosome Potential, Evox Eyes Unicorn Status
A financing round that was significantly oversubscribed by new and existing investors will help advance the Oxford-headquartered biotech's exosome therapeutics into the clinic and expand its technology platform.